Anaveon
PrivateLast Round
Series B
Dec 16, 2021
Est. Valuation
$248.5M
Total Funding Raised
$155.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Anaveon is a biotechnology company that develops next-generation precision biologics designed to selectively modulate the immune system for the treatment of autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anaveon Comparables
Compare Anaveon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthekine | 83% | |
| Aulos Bioscience | 80% | |
| Medicenna Therapeutics Corp | 78% |
Anaveon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 16, 2021 | ||||
| Series A | Feb 26, 2019 | ||||
| Grant | Dec 1, 2017 |
Key People
Founding team and executive leadership
Anaveon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series B |
| Forbion | Series B |
| Syncona | Series B, Series A |
| Pontifax Venture Capital | Series B |
| Pontifax Credit | Series B |
| TD Securities | Series B |
| Blue Owl Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 303% MoM, from 524 to 2.1K.
- Mar 23, 2026
Thaminda Ramanayake appointed as new Chief Executive Officer.
Recent news
Latest coverage and updates
- promotesJul 3, 2026
Anaveon promoted Laetitia Pouzol to Chief Scientific Officer on Jul 3rd '26.
- hiresJul 2, 2026
Anaveon hired Laetitia Pouzol as Chief Scientific Officer on Jul 2nd '26.
Anaveon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anaveon's valuation, stock price, and market status.
Is Anaveon a public or private company?
Anaveon is a private company.
What is the current stock price of Anaveon?
Anaveon is a private company with no public stock price. No recent secondary market data is available.
How much is Anaveon worth (valuation)?
Anaveon's valuation is estimated at $207.0M based on funding round data.
Can I buy Anaveon stock?
Anaveon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Anaveon's last funding round?
Anaveon's most recent funding round was Series B on December 16, 2021.
Who are the main investors in Anaveon?
Key investors in Anaveon include Forbion Capital Partners, Syncona.
Will Anaveon IPO soon?
No public IPO plans have been announced for Anaveon.
How can I track Anaveon secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anaveon's secondary market activity and sign up for updates.